Cardiovasculair risico bij reumapatiënten behandeld met biologicals of tofacitinib

Bronnen:

1. Nurmohamed M, Choy E, Lula S, et al. The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review. Drug Saf. 2018 Jan 9. [Epub ahead of print]